NCT06184334View on ClinicalTrials.gov

Management of OAB in Female Patients .

NACompletedINTERVENTIONAL

Enrollment

300

Participants

Timeline

Start Date

September 14, 2022

Primary Completion Date

December 1, 2022

Study Completion Date

December 1, 2023

Conditions

Overactive Bladder

Interventions

DRUG

Solfenacin

pills taken once day

DRUG

Mirabegron

pills taken once day

DRUG

Tadalafil 5mg

pills taken once day

Trial Locations (1)

Unknown

Kafrelsheikh University hospital, Kafr ash Shaykh

All Listed Sponsors

lead

Elsayed Abdelhalim Elsayed

OTHER